Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 1 , ISSUE 2 ( April-June, 2007 ) > List of Articles


Contrast-enhanced Ultrasound in Obstetrics and Gynecology

Jun Murotsuki

Keywords : Contrast media,ultrasonography,obstetrics,gynecology,placental blood flow

Citation Information : Murotsuki J. Contrast-enhanced Ultrasound in Obstetrics and Gynecology. Donald School J Ultrasound Obstet Gynecol 2007; 1 (2):16-19.

DOI: 10.5005/jp-journals-10009-1094

License: CC BY-NC 4.0

Published Online: 01-06-2008

Copyright Statement:  Copyright © 2007; The Author(s).


Ultrasonography is a well-established imaging modality for evaluation of gynecologic tumors. In recent years, more sophisticated technologies like the use of intravascular contrast agents led to an improvement in the ability of the practitioner to differentiate benign from malignant masses. When we consider the safety of contrast-enhanced ultrasonography in obstetrics and gynecology, we must discuss about the effect of ultrasound contrast media on embryo and fetus. The use of ultrasound contrast media in pregnant women always concerns in the obstetricians because of the principle of not exposing a fetus to any drug. Therefore, the literature was reviewed for information about those safety and efficacy because of the uncertainty about the use of contrast media during pregnancy. Based on the limited information available, mutagenic and teratogenic effects have not been described after administration of ultrasound contrast media. No effect on the fetus has been seen after contrast media. The small potential risk associated with the nonthermal bioeffects via acoustic cavitation may be considered to prohibit the use in first trimester pregnant women. In previous studies including human trials, no evidence of adverse effect was reported. Contrast-enhanced ultrasonography could prove a useful adjunct in multiple gestations and in evaluation of uteroplacental circulation. It appears to be very promising potential in obstetrics.

PDF Share
  1. Contrast echocardiography: new agents. Ultrasound Med Biol 2004;30:425-34.
  2. Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast materials. Am Heart J 2000;139:675-83.
  3. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000;13:331-42
  4. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol 2004;287:H450-7.
  5. Stimulated acoustic emission to image a late liver- and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999;25:1341-52.
  6. Brain perfusion and ultrasonic imaging techniques. Eur J Ultrasound 2002;16:91-104.
  7. Microbubble contrast agent for color Doppler US: effect on breast masses. Radiology 1996;198:679-86.
  8. Contrast angiosonography: a technology to improve Doppler ultrasound examinations of the prostate. Eur Urol J 1999;35:9-20.
  9. Visualization of blood flow in small ovarian tumor vessels by transvaginal color Doppler sonography after echo enhancement with injection of Levovist. Gynecol Obstet Invest 1994;38:210-12
  10. Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses. Obstet Gynecol 2000;96:452-58.
  11. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases. J Ultrasound Med 2005;24:1267-78.
  12. Hysterosalpingo-contrast sonography (HyCoSy) using Echovist 200 in the outpatient investigation of infertility patients. Ultrasound Obstet Gynecol 1999;14:200-204.
  13. Hysterosalpingo-contrast-sonography (HyCoSy) with SHU 454 (Echovist®) for the assessment of tubal pregnancy. Hum Reprod 1998;13:3049-56.
  14. Assessment of fallopian tube patency by HyCoSy: comparison of a positive contrast agent with saline solution. Ultrasound Obstet Gynecol 2002;20:386-9.
  15. Sonohysterography for endometrial abnormalities: preliminary results. J Clin Ultrasound. 1993;21:87-95.
  16. Ultrasonic lithotripsy and soft tissue. World J Urol 1985;3:27-32
  17. Australian categorisation of drugs.
  18. Ultrasound contrast agents nucleate inertial cavitation in vitro. Ultrasound Med Biol 1995;21:1059-65.
  19. Sonochemicals increase the mutation frequency of V79 cells in vitro. Ultrasound Med Biol 1998;24:1209-13.
  20. The sensitivity of biological tissues to ultrasound. Ultrasound Med Biol 1997;23:805-12.
  21. The use of Levovist (SH U 508A) for echo-enhancement of vascular Doppler imaging in clinical diagnosis. Angiology 1996;47:S3-8.
  22. Increased signal intensity of velocity measurements in duplex sonography by using the contrast agent levovist: a prospective, randomized study in a fetal sheep model. Rofo 2004;176:91-7.
  23. Sonographic evaluation of intervillous flow in early pregnancy: use of echo-enhancement agents. Ultrasound Obstet Gynecol 1998;11:204-208.
  24. Assessment of fetal and placental blood flow in primates using contrast enhanced ultrasonography. J Ultrasound Med 1998;17:75-80.
  25. Contrast-enhanced ultrasonography of uteroplacental circulation does not evoke harmful CTG changes or perinatal events. Fetal Diagn Ther 2000;15:139-45.
  26. Intervillous blood flow in the third trimester gravid rhesus monkey (Macaca mulatta): use of sonographic contrast agent and harmonic imaging. Placenta 2001;22:200-5.
  27. Contrast sonography, video densitometry and intervillous blood flow: a pilot study. Placenta 2006;27:719-26.
  28. Sonographic investigation of flow patterns in the perfused human placenta and their modulation by vasoactive agents with enhanced visualization by the ultrasound contrast agent Albunex. J Clin Ultrasound 1999;27:513-22.
  29. Ex vivo delineation of placental angioarchitecture with the microbubble contrast agent Levovist. Am J Obstet Gynecol 2000;182:966-71.
  30. Intravascular ultrasound contrast agents: an aid in imaging intervillous blood flow? Placenta 1999;20:235-40.
  31. Ultrasound microbubble contrast angiography in monochorionic twin fetuses. Lancet 1997;349:773.
  32. Twin fetuses: intravascular microbubble US contrast agent administration- early experience. Radiology 2000;214:724-8.
  33. Intravascular contrast agent in the ultrasonography of ectopic pregnancy. Ultrasound Obstet Gynecol 1999;14:348-52.
  34. Placenta accreta: imaging by gray-scale and contrast-enhanced color Doppler sonography and magnetic resonance imaging. J Clin Ultrasound 1998;26:90-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.